SURGEPAYS INC
SURGNASDAQ🏆 #3644 by market capUS Equity
$479.76▼ $26.77 (−5.58%)
Simulated price1h—
24h▼ 5.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$14M
Small Cap
📈Revenue Growth (YoY)
+55.8%
High Growth
📊Gross Margin
-24.6%
Thin
💵FCF Margin
22.6%
Strong
⚖️P/S Ratio
0.2x
Cheap
Otter Score
44
Weak
No chart data available for SURG.
Trading Snapshot
- Day Range
- $477.62 – $487.28
- 52-Week Range
- $0.34 – $3.45
- Volume
- $2.11B
- Avg Volume
- $1.76B
- Shares Outstanding
- 25.1M
- Next Earnings
- Sep 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $62M
- Last Q Revenue
- $17M
- P/E Ratio
- —
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-1.92
- Dividend Yield
- —
Why Investors Own SURG
- ✓High-growth profile — revenue up +35.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 28% gross margin and 29% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$62M▲ +39.7% YoY
Gross Margin (TTM)
27.7%▲ +1.8% YoY
Operating Income (TTM)
$15M▲ +39.7% YoY
Free Cash Flow (TTM)
$18M▲ +39.7% YoY
About SURGEPAYS INC
A company profile for SURGEPAYS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
44/100
Analyst Price Target
ⓘAverage Target
$629.95
▲ +31.3% Upside
High Target$694.13
Low Target$479.41
Based on 13 analysts
Latest News & Updates
🚀
Reuters·2h ago
SURGEPAYS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift SURG price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
SURGEPAYS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.